共 326 条
[21]
Jenkins RB(2015)Epidermal growth factor receptor in non-small cell lung cancer Transl Lung Cancer Res 4 110-660
[22]
Kwiatkowski DJ(2013)Immunostaining with EGFR mutation-specific antibodies: a reliable screening method for lung adenocarcinomas harboring EGFR mutation in biopsy and resection samples Hum Pathol 44 1499-1214
[23]
Saldivar JS(2015)Identification of EGFR mutations by immunohistochemistry with EGFR mutation-specific antibodies in biopsy and resection specimens from pulmonary adenocarcinoma Cancer Res Treat 47 653-132
[24]
Squire J(2013)Frequency and type of epidermal growth factor receptor mutations in Moroccan patients with lung adenocarcinoma J Thorac Oncol 8 1212-590
[25]
Thunnissen E(2014)Patients harboring epidermal growth factor receptor (EGFR) double mutations had a lower objective response rate than those with a single mutation in non-small cell lung cancer when treated with EGFR-tyrosine kinase inhibitors Thorac Cancer 5 126-506
[26]
Ladanyi M(2017)EGFR-co-mutated advanced NSCLC and response to EGFR tyrosine kinase inhibitors J Thorac Oncol 12 585-122
[27]
Leighl NB(2007)Epidermal growth factor receptor double activating mutations involving both exons 19 and 21 exist in Chinese non-small cell lung Cancer patients Clin Oncol 19 499-655
[28]
Rekhtman N(2013)Compound EGFR mutations and response to EGFR tyrosine kinase inhibitors J Thorac Oncol 8 118-346
[29]
Biermann WA(2010)Frequency of and variables associated with the EGFR mutation and its subtypes Int J Cancer 126 651-202
[30]
Huang J(2005)Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers J Natl Cancer Inst 97 339-151